These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8499148)

  • 1. Indication and limits of megatherapy and bone marrow transplantation in high-risk neuroblastoma: a single centre analysis of prognostic factors.
    Ladenstein R; Favrot M; Lasset C; Bouffet E; Philip I; Combaret V; Chauvin F; Brunat-Mentigny M; Biron P; Philip T
    Eur J Cancer; 1993; 29A(7):947-56. PubMed ID: 8499148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry.
    Ladenstein R; Philip T; Lasset C; Hartmann O; Garaventa A; Pinkerton R; Michon J; Pritchard J; Klingebiel T; Kremens B; Pearson A; Coze C; Paolucci P; Frappaz D; Gadner H; Chauvin F
    J Clin Oncol; 1998 Mar; 16(3):953-65. PubMed ID: 9508178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 study.
    Philip T; Ladenstein R; Zucker JM; Pinkerton R; Bouffet E; Louis D; Siegert W; Bernard JL; Frappaz D; Coze C
    Br J Cancer; 1993 Jan; 67(1):119-27. PubMed ID: 8427772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial.
    Berthold F; Boos J; Burdach S; Erttmann R; Henze G; Hermann J; Klingebiel T; Kremens B; Schilling FH; Schrappe M; Simon T; Hero B
    Lancet Oncol; 2005 Sep; 6(9):649-58. PubMed ID: 16129365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions. European Group for Blood and Marrow Transplant Registry Solid Tumour Working Party.
    Philip T; Ladenstein R; Lasset C; Hartmann O; Zucker JM; Pinkerton R; Pearson AD; Klingebiel T; Garaventa A; Kremens B; Bernard JL; Rosti G; Chauvin F
    Eur J Cancer; 1997 Oct; 33(12):2130-5. PubMed ID: 9516868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European Group for Bone Marrow Transplantation.
    Ladenstein R; Lasset C; Hartmann O; Frappaz D; Garaventa A; Klingebiel T; Zucker JM; Coze C; Burdach S; Gadner H
    J Clin Oncol; 1993 Dec; 11(12):2330-41. PubMed ID: 8246022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour Registry.
    Ladenstein R; Lasset C; Pinkerton R; Zucker JM; Peters C; Burdach S; Pardo N; Dallorso S; Coze C
    Bone Marrow Transplant; 1995 May; 15(5):697-705. PubMed ID: 7670398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does megatherapy contribute to survival in metastatic neuroblastoma? A retrospective analysis. German Cooperative Neuroblastoma Study Group.
    Hero B; Kremens B; Klingebiel T; Bender-Götze C; Burdach S; Schrappe M; Berthold F
    Klin Padiatr; 1997; 209(4):196-200. PubMed ID: 9293450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institution.
    Hartmann O; Valteau-Couanet D; Vassal G; Lapierre V; Brugières L; Delgado R; Couanet D; Lumbroso J; Benhamou E
    Bone Marrow Transplant; 1999 Apr; 23(8):789-95. PubMed ID: 10231141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.
    Stram DO; Matthay KK; O'Leary M; Reynolds CP; Haase GM; Atkinson JB; Brodeur GM; Seeger RC
    J Clin Oncol; 1996 Sep; 14(9):2417-26. PubMed ID: 8823319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloablative therapy and bone marrow rescue in advanced neuroblastoma. Report from the Italian Bone Marrow Transplant Registry. Italian Association of Pediatric Hematology-Oncology, BMT Group.
    Garaventa A; Rondelli R; Lanino E; Dallorso S; Dini G; Bonetti F; Arrighini A; Santoro N; Rossetti F; Miniero R; Andolina M; Amici A; Indolfi P; Lo Curto M; Favre C; Paolucci P; Pession A; De Bernardi B
    Bone Marrow Transplant; 1996 Jul; 18(1):125-30. PubMed ID: 8832005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study].
    Ladenstein R; Ambros PF; Urban C; Ambros IM; Fink FM; Zoubek A; Grienberger H; Schmitt K; Kerbl R; Horcher E; Amann G; Höfler G; Heinzl H; Gadner H; Mutz I
    Klin Padiatr; 1996; 208(4):210-20. PubMed ID: 8926686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal clinical and functional pulmonary follow-up after megatherapy, fractionated total body irradiation, and autologous bone marrow transplantation for metastatic neuroblastoma.
    Nève V; Foot AB; Michon J; Fourquet A; Zucker JM; Boulé M
    Med Pediatr Oncol; 1999 Mar; 32(3):170-6. PubMed ID: 10064183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of TBI on late effects in children treated by megatherapy for Stage IV neuroblastoma. A study of the French Society of Pediatric oncology.
    Flandin I; Hartmann O; Michon J; Pinkerton R; Coze C; Stephan JL; Fourquet B; Valteau-Couanet D; Bergeron C; Philip T; Carrie C
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1424-31. PubMed ID: 16427213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of myeloablative therapy in improved outcome for high risk neuroblastoma: review of recent Children's Cancer Group results.
    Matthay KK; O'Leary MC; Ramsay NK; Villablanca J; Reynolds CP; Atkinson JB; Haase GM; Stram DO; Seeger RC
    Eur J Cancer; 1995; 31A(4):572-5. PubMed ID: 7576971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive chemotherapy with stem cell support-experience in pediatric solid tumours.
    Pinkerton CR
    Bull Cancer; 1995; 82 Suppl 1():61s-65s. PubMed ID: 7626856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose chemotherapy with autologous bone marrow rescue in advanced stage IV neuroblastoma.
    Garaventa A; Ladenstein R; Chauvin F; Lanino E; Philip I; Corciulo P; Brisigotti M; Favrot M; Dini G; Philip T
    Eur J Cancer; 1993; 29A(4):487-91. PubMed ID: 8435197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of myeloablative therapy with bone marrow transplantation in advanced neuroblastoma.
    Matthay KK
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S21-4. PubMed ID: 8971402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metastatic neuroblastoma: consolidation treatment with 2 courses of high-dose chemotherapy followed by a bone marrow autograft].
    Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
    Bull Cancer; 1988; 75(1):119-23. PubMed ID: 3282574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous bone marrow transplantation for very bad prognosis neuroblastoma.
    Philip T; Biron P; Philip I; Favrot M; Bernard JL; Zucker JM; Lutz B; Plouvier E; Rebattu P; Carton M
    Prog Clin Biol Res; 1985; 175():569-86. PubMed ID: 3887433
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.